Do Molecular Profiles of Primary Versus Metastatic Radioiodine Refractory Differentiated Thyroid Cancer Differ?
Gomes-Lima CJ, Shobab L, Wu D, Ylli D, Bikas A, McCoy M, Feldman R, Lee W, Rao SN, Jensen K, Vasko V, Castro LC, Jonklaas J, Wartofsky L, Burman KD.
Gomes-Lima CJ, et al. Among authors: shobab l.
Front Endocrinol (Lausanne). 2021 Feb 25;12:623182. doi: 10.3389/fendo.2021.623182. eCollection 2021.
Front Endocrinol (Lausanne). 2021.
PMID: 33716974
Free PMC article.